Attached files
file | filename |
---|---|
EX-1 - EXHIBIT 1 - PRAXAIR INC | ex1.htm |
EX-5 - EXHIBIT 5 - PRAXAIR INC | ex5.htm |
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
————————————
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 11, 2010
————————————
PRAXAIR,
INC.
(Exact
name of registrant as specified in its charter)
————————————
Delaware
|
1-11037
|
06-1249050
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
file number)
|
(I.R.S.
Employer
Identification
No.)
|
39
Old Ridgebury Road
Danbury,
CT 06810-5113
(Address
of principal executive offices)
(203) 837-2000
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
————————————
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
1.01. Entry
into a Material Definitive Agreement.
On January 14, 2010, Praxair, Inc. (the
“Company”) issued $500,000,000 aggregate principal amount of 2.125% notes due
2013 (the “Notes”). The Notes were sold in a registered offering
under the Securities Act of 1933, pursuant to the Company’s shelf registration
statement on Form S-3 filed with the Securities and Exchange Commission (“SEC”)
on November 9, 2009. The material terms of the Notes are described in
the Company’s prospectus supplement dated January 11, 2010 filed with the SEC on
January 12, 2010.
In connection with the issuance of the
Notes, the Company entered into a Terms Agreement dated January 11, 2010 (the
“Terms Agreement”) with Citigroup Global Markets Inc., HSBC Securities (USA)
Inc. and RBS Securities Inc., as representatives of the underwriters named
therein (the “Underwriters”). Pursuant to and subject to the terms
and conditions of the Terms Agreement, the Underwriters agreed to purchase the
Notes from the Company for resale in the registered offering. The
Terms Agreement is filed as Exhibit 1 to this Form 8-K.
In connection with the Notes offering,
Cahill Gordon & Reindel llp provided certain
legal opinions to the Company that are filed as Exhibit 5 to this Form
8-K.
Item
9.01. Financial
Statements and Exhibits.
(d)
Exhibits. The following exhibits are furnished herewith:
Exhibit No.
|
Description
|
1
|
Terms
Agreement dated January 11, 2010
|
5
|
Opinion
of Cahill Gordon & Reindel llp
|
23
|
Consent
of Cahill Gordon & Reindel llp (included in
Exhibit 5)
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
January 14, 2010
PRAXAIR,
INC.
By:
/s/ James T.
Breedlove
James
T. Breedlove
Senior
Vice President,
General
Counsel and Secretary
|
Exhibit
Index
Exhibit
No.
|
Description
|
1
|
Terms
Agreement dated January 11, 2010
|
5
|
Opinion
of Cahill Gordon & Reindel llp
|
23
|
Consent
of Cahill Gordon & Reindel llp (included in
Exhibit 5)
|